DD
46
-3
EXR
62
3
WU
24
2
FOX
20
-2
VFC
47
9
CL
72
6
SYK
60
-4
MAS
54
3
ZTS
49
-9
GOOGL
62
-5
IFF
51
-5
ADT
23
-2
RIG
31
-6
OMC
48
-6
HUM
35
5
XEL
48
-3
BAC
42
9
CCL
44
-4
MLM
69
3
BMY
37
-4
DD
46
-3
EXR
62
3
WU
24
2
FOX
20
-2
VFC
47
9
CL
72
6
SYK
60
-4
MAS
54
3
ZTS
49
-9
GOOGL
62
-5
IFF
51
-5
ADT
23
-2
RIG
31
-6
OMC
48
-6
HUM
35
5
XEL
48
-3
BAC
42
9
CCL
44
-4
MLM
69
3
BMY
37
-4
Financhill
Back

Haemonetics 10K Form

Sell
47

HAE
Haemonetics

Last Price:
84.66
Seasonality Move:
7.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-02-08 10Q HAE/Haemonetics Quarterly
2023-11-02 10Q HAE/Haemonetics Quarterly
2023-08-08 10Q HAE/Haemonetics Quarterly
2023-02-07 10Q HAE/Haemonetics Quarterly
2022-11-08 10Q HAE/Haemonetics Quarterly
2022-08-10 10Q HAE/Haemonetics Quarterly

Receive HAE News And Ratings

See the #1 stock for the next 7 days that we like better than HAE

HAE Financial Statistics

Sales & Book Value

Annual Sales: $1.31B
Cash Flow: $54.4M
Price / Cash Flow: 38.31
Annual Sales: $18.90
Price / Book: 4.56

Profitability

EPS (TTM): 2.29000
Net Income (TTM): $117.56M
Gross Margin: $691.55M
Return on Equity: 13.12%
Return on Assets: 5.7%

Haemonetics Earnings Forecast

Key Haemonetics Financial Ratios

  • The Gross Profit Margin over the past 33 years for HAE is 52.83%.
  • The Selling, General & Administrative Expenses for HAE have been equal to 32.98% of Gross Profit Margin.
  • The Research & Development expenses have been 4.16% of Revenue.
  • The Interest Expense is 11.07% of Operating Income.
  • The Net Earning history of HAE is 8.98% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 21 years.

Haemonetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: HAE
CUSIP: 405024
Website: haemonetics.com

Debt

Debt-to-Equity Ratio: 0.84
Current Ratio: 2.56
Quick Ratio: 1.28

Price-to-Earnings

Trailing P/E Ratio: 37.58
Forward P/E Ratio: 15.81

HAE Technical Analysis vs Fundamental Analysis

Sell
47
Haemonetics (HAE) is a Sell

Is Haemonetics a Buy or a Sell?

  • Haemonetics stock is rated a Sell
    The current Haemonetics [HAE] share price is $86.05. The Score for HAE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.